Bernhard Bielesz
Overview
Explore the profile of Bernhard Bielesz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alesutan I, Razazian M, Luong T, Estepa M, Pitigala L, Henze L, et al.
Kidney Int
. 2024 Jul;
106(4):611-624.
PMID: 39084258
Medial vascular calcification in chronic kidney disease (CKD) involves pro-inflammatory pathways induced by hyperphosphatemia. Several interleukin 6 family members have been associated with pro-calcific effects in vascular smooth muscle cells...
2.
Bojic M, Cejka D, Bielesz B, Schernthaner G, Hobaus C
Atherosclerosis
. 2023 Mar;
370:12-17.
PMID: 36898866
Background And Aims: Secondary calciprotein particles (CPP-II) induce inflammation and contribute to vascular calcification. CPP-II size is associated with vascular calcification in patients with chronic kidney disease (CKD) and all-cause...
3.
Bojic M, Bielesz B, Cejka D, Schernthaner G, Hobaus C
Thromb Haemost
. 2021 Oct;
122(6):1040-1046.
PMID: 34719013
Peripheral artery disease (PAD) has been shown to be linked to elevated cardiovascular risk. The novel T test quantifies calcification propensity of serum and has been associated with cardiovascular events...
4.
Bielesz B, Lorenz M, Monteforte R, Prikoszovich T, Gabriel M, Wolzt M, et al.
Clin J Am Soc Nephrol
. 2021 Sep;
16(10):1512-1521.
PMID: 34470831
Background And Objectives: Whether iron supplementation in patients on hemodialysis could be delivered by less frequent but higher single doses compared with the currently more common higher-frequency schedules of lower...
5.
Bojic M, Koller L, Cejka D, Niessner A, Bielesz B
Front Med (Lausanne)
. 2021 Jul;
8:672348.
PMID: 34222283
The propensity of serum to calcify, as assessed by the T-test, associates with mortality in patients with chronic kidney disease. In chronic heart failure, phosphate and fibroblast growth factor-23 (FGF-23),...
6.
Bielesz B, Reiter T, Hammerle F, Winnicki W, Bojic M, Gleiss A, et al.
J Clin Med
. 2020 Aug;
9(8).
PMID: 32823844
Anemia in chronic kidney disease (CKD) is an almost universal complication of this condition. Fibroblast growth factor 23 (FGF23), a key-player in mineral metabolism, is reportedly associated with anemia and...
7.
Winnicki W, Sunder-Plassmann G, Sengolge G, Handisurya A, Herkner H, Kornauth C, et al.
Sci Rep
. 2019 Sep;
9(1):13783.
PMID: 31551522
The plasma soluble urokinase-type plasminogen activator receptor (suPAR) is a biomarker for focal segmental glomerulosclerosis (FSGS), but its value is under discussion because of ambiguous results arising from different ELISA...
8.
Bielesz B, Reiter T, Marculescu R, Gleiss A, Bojic M, Kieweg H, et al.
Sci Rep
. 2017 Dec;
7(1):17941.
PMID: 29263429
Vascular calcification is a component of cardiovascular disease, which is leading cause of death in patients with chronic kidney disease (CKD). A functional assay (T50-test) measuring the propensity of human...
9.
Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikic Z, Bielesz B, et al.
Kidney Int
. 2017 Sep;
93(3):753-760.
PMID: 28890326
Catheter-related infections and dysfunction are the main catheter complications causing morbidity and mortality in hemodialysis patients. However, there are no consistent data for the choice of catheter lock solutions for...
10.
Bielesz B, Patsch J, Fischer L, Bojic M, Winnicki W, Weber M, et al.
PLoS One
. 2017 Feb;
12(2):e0171873.
PMID: 28199411
Hemodialysis (HD) patients face increased fracture risk, which is further associated with elevated risk of hospitalization and mortality. High-resolution peripheral computed tomography (HR-pQCT) has advanced our understanding of bone disease...